These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 31638832)

  • 21. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus.
    Tang L; Wang H; Dai B; Wang X; Zhou D; Shen J; Guo F; Wang J; Zhou J; Wang H; Wu Q; Yao H; Gong T; Su J; Meng ZX; Niu T; Zhang L; Liang P
    J Mol Cell Cardiol; 2020 May; 142():53-64. PubMed ID: 32251671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
    Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
    Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome.
    Sun Y; Su J; Wang X; Wang J; Guo F; Qiu H; Fan H; Cai D; Wang H; Lin M; Wang W; Feng Y; Fu G; Gong T; Liang P; Jiang C
    EBioMedicine; 2023 Sep; 95():104741. PubMed ID: 37544203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
    Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.
    Mori H; Xu D; Shimoda Y; Yuan Z; Murakata Y; Xi B; Sato K; Yamamoto M; Tajiri K; Ishizu T; Ieda M; Murakoshi N
    Sci Rep; 2024 Jul; 14(1):15422. PubMed ID: 38965264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
    Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Relaxation in Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Pathogenic
    Wang R; Hasegawa M; Suginobe H; Yoshihara C; Ishii Y; Ueyama A; Ueda K; Hashimoto K; Hirose M; Ishii R; Narita J; Watanabe T; Kawamura T; Taira M; Ueno T; Miyagawa S; Ishida H
    J Am Heart Assoc; 2024 Mar; 13(6):e032375. PubMed ID: 38497452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
    Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
    Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
    Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
    Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.
    Jiang Y; Habibollah S; Tilgner K; Collin J; Barta T; Al-Aama JY; Tesarov L; Hussain R; Trafford AW; Kirkwood G; Sernagor E; Eleftheriou CG; Przyborski S; Stojković M; Lako M; Keavney B; Armstrong L
    Stem Cells Transl Med; 2014 Apr; 3(4):416-23. PubMed ID: 24591732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disrupted Ca
    Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
    Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
    Hallas T; Eisen B; Shemer Y; Ben Jehuda R; Mekies LN; Naor S; Schick R; Eliyahu S; Reiter I; Vlodavsky E; Katz YS; Õunap K; Lorber A; Rodenburg R; Mandel H; Gherghiceanu M; Binah O
    J Cell Mol Med; 2018 Feb; 22(2):913-925. PubMed ID: 29193756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells.
    Pavlova SV; Shulgina AE; Zakian SM; Dementyeva EV
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.
    Zhan Y; Sun X; Li B; Cai H; Xu C; Liang Q; Lu C; Qian R; Chen S; Yin L; Sheng W; Huang G; Sun A; Ge J; Sun N
    J Mol Cell Cardiol; 2018 Apr; 117():49-61. PubMed ID: 29452156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome.
    Belbachir N; Portero V; Al Sayed ZR; Gourraud JB; Dilasser F; Jesel L; Guo H; Wu H; Gaborit N; Guilluy C; Girardeau A; Bonnaud S; Simonet F; Karakachoff M; Pattier S; Scott C; Burel S; Marionneau C; Chariau C; Gaignerie A; David L; Genin E; Deleuze JF; Dina C; Sauzeau V; Loirand G; Baró I; Schott JJ; Probst V; Wu JC; Redon R; Charpentier F; Le Scouarnec S
    Eur Heart J; 2019 Oct; 40(37):3081-3094. PubMed ID: 31114854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.